Cargando…
Predictors of Mortality in Tocilizumab-Treated Severe COVID-19
Purpose: Tocilizumab is associated with positive outcomes in severe COVID-19. We wanted to describe the characteristics of nonresponders to treatment. Methods: This was a retrospective multicenter study in two respiratory departments investigating adverse outcomes at 90 days from diagnosis in subjec...
Autores principales: | Pagkratis, Konstantinos, Chrysikos, Serafeim, Antonakis, Emmanouil, Pandi, Aggeliki, Kosti, Chrysavgi Nikolaou, Markatis, Eleftherios, Hillas, Georgios, Digalaki, Antonia, Koukidou, Sofia, Chaini, Eleftheria, Afthinos, Andreas, Dimakou, Katerina, Papanikolaou, Ilias C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230711/ https://www.ncbi.nlm.nih.gov/pubmed/35746585 http://dx.doi.org/10.3390/vaccines10060978 |
Ejemplares similares
-
Mortality Among Hospitalized Patients With Pleural Effusions. A Multicenter, Observational, Prospective Study
por: Markatis, Eleftherios, et al.
Publicado: (2022) -
An unusual disease with an interesting sign
por: Afthinos, Andreas, et al.
Publicado: (2020) -
State-of-the-Art Treatments for Sarcoidosis
por: Papanikolaou, Ilias C., et al.
Publicado: (2022) -
Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model
por: Karampitsakos, Theodoros, et al.
Publicado: (2023) -
Corrigendum: Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)